Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (51 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Jan 2022 – 20 Aug 2026, limited by Sundaram ELSS Tax Saver Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Sundaram ELSS Tax Saver Fund | Nifty 500 |
|---|---|---|
| 03 Jan 2022 | ₹100.00 | ₹100.00 |
| 24 May 2022 | ₹91.10 | ₹90.42 |
| 12 Oct 2022 | ₹101.12 | ₹97.54 |
| 02 Mar 2023 | ₹99.72 | ₹95.94 |
| 20 Jul 2023 | ₹116.45 | ₹112.09 |
| 08 Dec 2023 | ₹125.67 | ₹123.01 |
| 27 Apr 2024 | ₹139.07 | ₹137.06 |
| 15 Sep 2024 | ₹157.96 | ₹157.37 |
| 03 Feb 2025 | ₹145.41 | ₹140.76 |
| 24 Jun 2025 | ₹155.68 | ₹152.01 |
| 11 Nov 2025 | ₹160.82 | ₹155.76 |
| 01 Apr 2026 | ₹142.18 | ₹137.69 |
| 20 Aug 2026 | ₹155.82 | ₹154.64 |
| Metric | Sundaram · Direct NAV ₹540.92 Very High risk ★★☆☆☆ | Category median ELSS · 51 funds |
|---|---|---|
| -2.47% | +3.05% | |
| +10.60% | +14.46% | |
| — | +13.60% | |
| — | +13.74% | |
| +10.06% | +14.97% | |
| +9.33% | — | |
| +14.83% | +16.84% | |
| — | +17.15% | |
| — | +15.41% | |
| Risk | ||
| 13.11% | 14.19% | |
| 0.31 | 0.52 | |
| 0.43 | 0.70 | |
| -16.66% | -35.94% | |
| Nifty 500 | — | |
| -0.79% | +1.57% | |
| 0.90 | 0.97 | |
| 89.3% | 102.3% | |
| 89.9% | 93.6% | |
| 1.76% | 1.06% | |
| ₹1,254Cr | ₹765.87Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 60% | 34% | |
| Sudhir Kedia | — | |
| 03 Jan 2022 | — | |
| 54 | — | |
| 42.5% | — | |
| 1.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.